ARTICLE | Product Development
Mapping opportunities for China’s early cancer detection boom
How Chinese companies developing liquid biopsies for cancer are approaching the potentially massive market
October 8, 2020 6:46 PM UTC
As investor enthusiasm for blood-based cancer screening soars in the wake of Grail’s $8 billion acquisition, much of the activity is taking place in China, where a short list of dominant ...